Gene · 6607
NIH grants1,484
NIH grants whose papers are about the gene, through NIH's grant-paper links.
161 to 180 of 1,484
Download this page as JSON| Grant | Title | SMN2 papers | Newest fiscal year |
|---|---|---|---|
| R01CA238249 | Integrated ligand and target discovery by chemical proteomics for glioblastoma treatment. | 1 | 2025 |
| R01CA244634 | The RNA structural code underlying pathological regulation of RNA splicing in metastasis | 1 | 2025 |
| R01CA247883 | Roles of Coactivator-Associated Arginine Methyltransferase 1 in B cell activation and lymphomagenesis | 1 | 2025 |
| R01CA248317 | MYC-regulated RNA Binding Protein Networks and Spliced Isoforms Driving Cancer | 1 | 2025 |
| R01CA254192 | Exosomes as carriers of cancer therapeutics | 1 | 2025 |
| R01DA033641 | Transgenerational Inheritance of a Cocaine Resistance Phenotype | 1 | 2025 |
| R01DK103723 | Regulation of enteric motor neurocircuits by enteric glia in health and disease | 1 | 2025 |
| R01EY014061 | SCA7 neurodegeneration: Molecular epigenetic basis and therapy | 1 | 2025 |
| R01EY024280 | Engineering AAV for safe and efficient gene delivery to the human retina | 1 | 2025 |
| R01GM070503 | Molecular Recognition During Pre-mRNA Splicing | 1 | 2025 |
| R01GM117275 | Protein N-terminal Methylation Mechanisms and Inhibition | 1 | 2025 |
| R01GM149631 | Engineering cell type-specific splicing regulation | 1 | 2025 |
| R01HD055651 | Prenatal Genetic Diagnosis by Genomic Sequencing: A Prospective Evaluation | 1 | 2025 |
| R01HD106051 | Quantitative mass spectrometry for comprehending epigenetic mechanisms in a new underlying neurological developmental disorder | 1 | 2025 |
| R01HD107190 | Uncovering the etiologies of non-immune hydrops fetalis through comprehensive genomic analyses and phenotyping | 1 | 2025 |
| R01HG010040 | Advanced computational methods in analyzing high-throughput sequencing data | 1 | 2025 |
| R01HG010169 | Sequence resolution of complex human genome structural variation | 1 | 2025 |
| R01HG011067 | Novel methods to detect and interpret splicing quantitative trait loci - Renewal | 1 | 2025 |
| R01HG011787 | A unified quantitative modeling strategy for multiplex assays of variant effect | 1 | 2025 |
| R01HL109557 | Mechanisms and Consequences of Gene Induction by Glucocorticoids in Airway Smooth Muscle | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/grants?page=9